Go Pro
NYSE:ABT

Abbott Laboratories Q3 2026 Earnings Report

Abbott Laboratories logo
$101.33 +0.26 (+0.26%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$101.26 -0.07 (-0.07%)
As of 09/25/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories EPS Results

Actual EPS
N/A
Consensus EPS
$1.42
Beat/Miss
N/A
One Year Ago EPS
N/A

Abbott Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
$12.99 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Abbott Laboratories Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Wednesday, October 14, 2026
Conference Call Time
9:00AM ET

Conference Call Resources

Abbott Laboratories Earnings Headlines

Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
What Makes Abbott Laboratories (ABT) an Attractive Opportunity?
See More Abbott Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abbott Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abbott Laboratories and other key companies, straight to your email.

About Abbott Laboratories

Abbott Laboratories (NYSE:ABT) (NYSE: ABT) is a global healthcare company that develops, manufactures and sells medical products and technologies. Its operations span four principal areas: medical devices, diagnostics, established pharmaceutical products and nutrition. Abbott serves healthcare providers, institutions and consumers in markets around the world.

The company’s medical device portfolio includes products for cardiovascular care, diabetes management and other specialties. Its diagnostics business provides laboratory systems, tests and point-of-care solutions, while its nutrition products include infant, child and adult nutritional offerings sold under brands such as Similac, Ensure and Pedialyte. Abbott also markets a broad range of branded generic pharmaceuticals in international markets.

Founded in 1888 by Wallace C. Abbott, the company is headquartered in Abbott Park, Illinois, and has expanded from its origins as a pharmaceutical business into a diversified healthcare company. Abbott’s products are marketed in more than 160 countries. Robert B. Ford serves as the company’s chairman and chief executive officer.

View Abbott Laboratories Profile